Navigation Links
Diabetes Social Networking Web Sites Vary in Quality

By Serena Gordon
HealthDay Reporter

FRIDAY, Feb. 18 (HealthDay News) -- The quality of social networking sites for people with diabetes varies greatly, researchers say, with some providing useful medical information and emotional support, while others may simply be thinly veiled advertising sites.

Only half of the sites researchers from Children's Hospital Boston reviewed contained content that was in line with current diabetes science and clinical practice, the study found.

"This study was an attempt to rigorously review online social networking communities focused on diabetes, not Web sites and not bulletin board communities," said lead author Elissa Weitzman, an assistant professor at Harvard Medical School and the Children's Hospital Informatics Program in Boston.

"People are in these communities to address an overwhelming need for information and social communication. And, we found that a couple of sites consistently did better than others," she added.

Weitzman declined to name those sites, explaining the study was designed to evaluate the social networks overall, not to provide specific reviews. Also, some of the networks reviewed may not be active anymore.

The researchers reviewed the top 10 diabetes social networks, according to a Google search. They evaluated each one for the accuracy of its diabetes science; safety practices (Were sites monitored by moderators? Were conflicts of interest apparent? How was misinformation handled?); accessibility of privacy policies, and the ability to change privacy settings. They also looked at how advertising was identified, how member data was shared and what control members had over their data.

Half the sites provided good medical information. Only three sites met most of the researchers' criteria with regard to safety, and only three sites posted information about network moderators. Eight networks had accessible privacy policies, but most were difficult to read. Each site varied as far as ability to change privacy settings or share data.

Three sites had advertisements for diabetes "cures," and two didn't clearly label these as advertisements.

Results of the study were published online recently in the Journal of the American Medical Informatics Association.

"It will be difficult for a consumer to judge a lot of these features," said senior author Dr. Kenneth Mandl, an associate professor at Harvard Medical School and Children's Hospital Informatics Program. "Based on the amount of activity in these social network communities, this phenomenon is reaching a stage of maturity that will require more oversight and responsibility on the part of the social networking sites, and more education on the part of the consumers."

Other experts say the study brings important issues to light. "In a time when privacy matters on Facebook -- the biggest social network of all -- are so top of mind, this study is very timely and relevant," said Manny Hernandez, founder of TuDiabetes, a social networking site for people with diabetes, and an insulin-dependent diabetic himself.

"We need to make sure people with chronic conditions like diabetes feel comfortable connecting with others online to become more empowered and informed patients, who can also get the support that is so important with this type of disease," he explained.

Red Maxwell, a volunteer for the Juvenile Diabetes Research Foundation and founder of its Juvenation social network for people with type 1 diabetes, said online social networks are still in their infancy.

"There is an exchange of a lot of private health information," he said. "There's an implicit trust that the information won't be abused, but we understand there's a risk, and some of us are willing to do it" in order to help others, he added.

Dr. Sue Kirkman, senior vice president of medical affairs and community information for the American Diabetes Association, said the association encourages "individuals to always be vigilant in protecting their personal information online, and to talk to their health-care provider for specific information about the treatment and management of their diabetes."

Using your own common sense is key, Hernandez and Maxwell said. Consider the source of the information and understand that "even among reputable sites, there are still people who just don't know what they're talking about," Maxwell added.

Select sites that follow better practices, the authors say. For instance, beware of any that promise "cures," look for credentialed moderators and check that basic medical information provided is consistent with your doctor's advice.

Be sure to read and understand the privacy policy of any social networks you participate in, they add.

And, remember that information you find online can never replace discussions and visits with your doctor.

More information

Here are some general tips for protecting yourself and your children on social networking sites from the U.S. government's OnGuardOnline Web site.

SOURCES: Elissa Weitzman, Sc.D., M.Sc., assistant professor, Harvard Medical School and Children's Hospital Informatics Program, Boston; Kenneth Mandl, M.D., M.P.H., associate professor, Harvard Medical School and Children's Hospital Informatics Program, Boston; Red Maxwell, volunteer, Juvenile Diabetes Research Foundation, and founder, Juvenation; Manny Hernandez, founder, TuDiabetes; Sue Kirkman, M.D., senior vice president, medical affairs and community information, American Diabetes Association; Jan. 24, 2011, Journal of the American Medical Informatics Association, online

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dwarfism Mutation May Protect From Cancer, Diabetes
2. Researchers find brain insulin plays critical role in the development of diabetes
3. Early signs of heart disease in preadolescent children with type 1 diabetes
4. Trial will test whether surgery is the best option for type 2 diabetes
5. Experts call for greater awareness of the links between diabetes and kidney disease
6. Cold Viruses Appear Linked to Type 1 Diabetes
7. Researchers discover root cause of blood vessel damage in diabetes
8. 6 million euros for European Diabetes Research Network
9. 105 Million in U.S. Have Diabetes or Prediabetes, CDC Says
10. Breast Cancer Patients With Diabetes May Fare Worse
11. Bright Lights at Night May Raise Diabetes Risk
Post Your Comments:
Related Image:
Diabetes Social Networking Web Sites Vary in Quality
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: